Sep 21, 2017
Atrial fibrillation increases your risk of clotting.
Anticoagulation increases your risk of bleeding. Surgery increases
your risk of both. Dr. Mike Rubenstein speaks with Dr. Jim Siegler
this week about how providers weigh the risks and benefits of
anticoagulant bridging in the perioperative setting.
Produced by Michael Rubenstein and James E. Siegler. Music by
Chris Zabriskie, Lee Rosevere, and Jason Shaw. Voiceover by Erika
Mejia. BrainWaves' podcasts and online content are intended for
medical education only and should not be used for clinical decision
- Rechenmacher SJ, Fang JC. Bridging anticoagulation: Primum non
nocere. Journal of the American College of Cardiology.
- Steinberg BA, Peterson ED, Kim S, Thomas L, Gersh BJ, Fonarow
GC, et al. Use and outcomes associated with bridging during
anticoagulation interruptions in patients with atrial fibrillation:
Findings from the outcomes registry for better informed treatment
of atrial fibrillation (orbit-af). Circulation.
- Stroke prevention in atrial fibrillation study. Final results.
- Garcia DA, Regan S, Henault LE, Upadhyay A, Baker J, Othman M,
et al. Risk of thromboembolism with short-term interruption of
warfarin therapy. Archives of internal medicine.
- Raval AN, Cigarroa JE, Chung MK, Diaz-Sandoval LJ, Diercks D,
Piccini JP, et al. Management of patients on non-vitamin k
antagonist oral anticoagulants in the acute care and periprocedural
setting: A scientific statement from the american heart
association. Circulation. 2017;135:e604-e633
- Schulman S, Carrier M, Lee AY, Shivakumar S, Blostein M,
Spencer FA, et al. Perioperative management of dabigatran: A
prospective cohort study. Circulation.